Cargando…

Dynamics of Inflammatory and Neurodegenerative Biomarkers after Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis

Autologous hematopoietic stem cell transplantation (aHSCT) is a highly efficient treatment of multiple sclerosis (MS), and hence it likely normalizes pathological and/or enhances beneficial processes in MS. The disease pathomechanisms include neuroinflammation, glial cell activation and neuronal dam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruder, Josefine, Dinner, Gianna, Maceski, Aleksandra, Berenjeno-Correa, Ernesto, Müller, Antonia Maria, Jelcic, Ilijas, Kuhle, Jens, Martin, Roland
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503241/ https://www.ncbi.nlm.nih.gov/pubmed/36142860 http://dx.doi.org/10.3390/ijms231810946

Ejemplares similares

B-Cell Reconstitution After Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis
por: von Niederhäusern, Valentin, et al.
Publicado: (2022)

NK Cells and Innate-Like T Cells After Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis
por: Ruder, Josefine, et al.
Publicado: (2021)

Differentiating neurosarcoidosis from multiple sclerosis using combined analysis of basic CSF parameters and MRZ reaction
por: Vlad, Benjamin, et al.
Publicado: (2023)

Effects of natalizumab therapy on intrathecal antiviral antibody responses in MS
por: Largey, Fabienne, et al.
Publicado: (2019)

T-Cell Specificity Influences Disease Heterogeneity in Multiple Sclerosis
por: Cruciani, Carolina, et al.
Publicado: (2021)

Autologous Hematopoietic Stem Cell Transplantation for Treatment of Systemic Sclerosis
por: Del Papa, Nicoletta, et al.
Publicado: (2018)

EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-γ and IL-2
por: Lünemann, Jan D., et al.
Publicado: (2008)

Autologous hematopoietic stem cell transplantation in progressive severe multiple sclerosis
por: Pandit, Awadh Kishor, et al.
Publicado: (2015)

Regenerating Immunotolerance in Multiple Sclerosis with Autologous Hematopoietic Stem Cell Transplant
por: Massey, Jennifer C., et al.
Publicado: (2018)

Life after Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis
por: Moraes, Daniela A, et al.
Publicado: (2021)

Neurofilament light chain predicts future dementia risk in cerebral small vessel disease
por: Egle, Marco, et al.
Publicado: (2021)

Central role of Th2/Tc2 lymphocytes in pattern II multiple sclerosis lesions
por: Planas, Raquel, et al.
Publicado: (2015)

Safety profile of autologous hematopoietic stem cell mobilization and transplantation in patients with systemic sclerosis
por: Helbig, Grzegorz, et al.
Publicado: (2017)

Autologous Hematopoietic Cell Transplantation in Multiple Sclerosis: Changing Paradigms in the Era of Novel Agents
por: Gavriilaki, Maria, et al.
Publicado: (2019)

Intensive immunosuppression followed by autologous hematopoietic stem cell transplantation for the treatment of multiple sclerosis
por: Lycke, Jan, et al.
Publicado: (2020)

Autologous Hematopoietic Stem Cell Transplantation (AHSCT): An Evolving Treatment Avenue in Multiple Sclerosis
por: Mohammadi, Reihane, et al.
Publicado: (2021)

Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis
por: Casanova, Bonaventura, et al.
Publicado: (2017)

New-onset refractory status epilepticus due to autoimmune encephalitis after vaccination against SARS-CoV-2: First case report
por: Werner, Jana, et al.
Publicado: (2022)

The role of innate immune cells in systemic sclerosis in the context of autologous hematopoietic stem cell transplantation
por: Servaas, N. H., et al.
Publicado: (2020)

Safety of Alemtuzumab and Autologous Hematopoietic Stem Cell Transplantation Compared to Noninduction Therapies for Multiple Sclerosis
por: Alping, Peter, et al.
Publicado: (2021)

Immunological Adverse Events After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients
por: Strunz, Patrick-Pascal, et al.
Publicado: (2021)

Real-world application of autologous hematopoietic stem cell transplantation in 507 patients with multiple sclerosis
por: Burt, Richard K., et al.
Publicado: (2021)

Autologous hematopoietic stem cell transplantation promotes connective tissue remodeling in systemic sclerosis patients
por: Zanin-Silva, Djúlio C., et al.
Publicado: (2022)

Autologous hematopoietic stem cell transplantation modifies specific aspects of systemic sclerosis-related microvasculopathy
por: Santana-Gonçalves, Maynara, et al.
Publicado: (2022)

Autologous Hematopoietic Stem-Cell Transplantation in Multiple Sclerosis: A Systematic Review and Meta-Analysis
por: Nabizadeh, Fardin, et al.
Publicado: (2022)

Anti-Müllerian hormone and pregnancy after autologous hematopoietic stem cell transplantation for multiple sclerosis
por: Zafeiri, Lida, et al.
Publicado: (2023)

Longitudinal analyses of serum neurofilament light and associations with obesity indices and bioelectrical impedance parameters
por: Hermesdorf, Marco, et al.
Publicado: (2022)

Post Transplantation Cyclophosphamide Improves Outcome of Autologous Hematopoietic Stem Cell Transplantation in Animal Model of Multiple Sclerosis
por: Kasarełło, Kaja, et al.
Publicado: (2021)

Autologous Hematopoietic Stem Cell Transplantation (AHSCT): Standard of Care for Relapsing–Remitting Multiple Sclerosis Patients
por: Bertolotto, Antonio, et al.
Publicado: (2020)

Long-term evaluation of autologous hematopoietic stem cell transplantation in a patient with progressive systemic sclerosis
por: KIM, Namho, et al.
Publicado: (2021)

Melphalan Culprit or Confounder in Acute Encephalopathy during Autologous Hematopoietic Stem Cell Transplantation?
por: Alayón-Laguer, Diógenes, et al.
Publicado: (2012)

Outcomes of Salvage Autologous Versus Allogeneic Hematopoietic Cell Transplantation for Relapsed Multiple Myeloma After Initial Autologous Hematopoietic Cell Transplantation
por: Wirk, Baldeep, et al.
Publicado: (2013)

EEG-Delta brushes in DPPX encephalitis – Welcome to the club
por: Heuer, Christine, et al.
Publicado: (2022)

Serum neurofilament light and tau as prognostic markers for all-cause mortality in the elderly general population—an analysis from the MEMO study
por: Rübsamen, Nicole, et al.
Publicado: (2021)

Immunosuppressive Therapy After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients—High Efficacy of Rituximab
por: Gernert, Michael, et al.
Publicado: (2022)

Rituximab as a Treatment Option after Autologous Hematopoietic Stem Cell Transplantation in a Patient with Systemic Sclerosis
por: Gressenberger, Paul, et al.
Publicado: (2021)

Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis Patients: Monocentric Case Series and Systematic Review of the Literature
por: Patti, Francesco, et al.
Publicado: (2022)

Autologous hematopoietic transplantation following COVID‐19 infection
por: Brzycki, Marthilde, et al.
Publicado: (2021)

Basic CSF parameters and MRZ reaction help in differentiating MOG antibody-associated autoimmune disease versus multiple sclerosis
por: Vlad, Benjamin, et al.
Publicado: (2023)

Autologous hematopoietic cell transplantation following high-dose immunosuppressive therapy for advanced multiple sclerosis: long-term results
por: Bowen, James D., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_pldgq7u05rg0msdh3i76fi32id